Ellenbogen Michael 4
4 · Evolv Technologies Holdings, Inc. · Filed Apr 17, 2026
Research Summary
AI-generated summary of this filing
Evolv (EVLV) Director Michael Ellenbogen Exercises Options, Sells Shares
What Happened
Michael Ellenbogen, a director of Evolv Technologies Holdings (EVLV), exercised stock options and immediately sold the resulting 80,745 shares on April 15, 2026. He paid $0.24 per share to exercise (total cost $19,379) and sold the shares in the open market for a weighted-average price of $6.32, generating proceeds of about $510,308. The filing also includes a related derivative conversion entry reported at $0.00.
Key Details
- Transaction date: April 15, 2026; Form 4 filed April 17, 2026.
- Exercise: 80,745 shares exercised at $0.24 per share (total $19,379). (Code M)
- Sale: 80,745 shares sold at a weighted-average price of $6.32 for proceeds ≈ $510,308. (Code S)
- Sale price range: $6.27 to $6.39 across multiple trades (footnote).
- Plan: Sales were executed pursuant to a Rule 10b5-1 trading plan entered June 12, 2025 (footnote).
- Vesting note: The option vests began Jan 31, 2018 with subsequent monthly vesting (footnote).
- Shares owned after transaction: Not specified in the provided filing.
- Timeliness: Filed two days after the transaction date (not indicated as late).
Context
This was an option exercise followed by immediate sale (a common "cashless" pattern for insiders converting options to cash). The 10b5-1 plan means the sales were pre-arranged. The filing is factual and does not by itself indicate the director’s view of the company’s prospects.
Insider Transaction Report
- Exercise/Conversion
Class A Common Stock
2026-04-15$0.24/sh+80,745$19,379→ 2,164,706 total - Sale
Class A Common Stock
[F1][F2]2026-04-15$6.32/sh−80,745$510,308→ 2,083,961 total - Exercise/Conversion
Stock Option (Right to Buy)
[F3]2026-04-15−80,745→ 1,139,249 totalExercise: $0.24Exp: 2027-09-13→ Class A Common Stock (80,745 underlying)
- 151,135(indirect: By Trust)
Class A Common Stock
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.27 to $6.39. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The option vested and become exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter.